A Double-Blind Trial Platform Based on Distributed Ledger Technology

• Published in: Electronics (Basel) Vol. 13; no. 1; p. 132
• Main Authors: Yeh, Yi-Hong, Hsueh, Sheng-Chun, Liang, Tyng-Yeu
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 01.01.2024
• Subjects: Access control; Blockchain; Clinical trials; Contracts; Data loss; Data security; Distributed ledger; Double-blind studies; Drugs; Electronic data processing; Experiments; Methods; Pharmaceutical industry; Placebo effect; Public participation; R&D; Research & development; Researchers; Technology application; Vaccines; Taiwan
• ISSN: 2079-9292; 2079-9292
• DOI: 10.3390/electronics13010132

In the pharmaceutical research and development process, the third phase of clinical trials involves double-blind trials to mitigate the influence of human subjective awareness on the experimental results and ensure the efficacy and safety of drugs or vaccines. However, conventional double-blind tria...